Success Metrics

Clinical Success Rate
50.0%

Based on 3 completed trials

Completion Rate
50%(3/6)
Active Trials
0(0%)
Results Posted
100%(3 trials)
Terminated
3(33%)

Phase Distribution

Ph phase_1
2
22%
Ph not_applicable
1
11%
Ph phase_3
2
22%
Ph phase_2
4
44%

Phase Distribution

2

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 2Efficacy & side effects
4(44.4%)
Phase 3Large-scale testing
2(22.2%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

33.3%

3 of 9 finished

Non-Completion Rate

66.7%

6 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(3)
Terminated(6)

Detailed Status

Terminated3
Completed3
Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (22.2%)
Phase 24 (44.4%)
Phase 32 (22.2%)
N/A1 (11.1%)

Trials by Status

terminated333%
completed333%
withdrawn333%

Recent Activity

0 active trials
Showing 5 of 9
terminatedphase_3

Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy

NCT05675319
withdrawnnot_applicable

Stem Cells vs. Steroids for Discogenic Back Pain

NCT04735185
terminatedphase_3

Maximizing Outcome of Multiple Sclerosis Transplantation

NCT03342638
terminatedphase_2

Cardiac Safe Transplants for Systemic Sclerosis

NCT03593902
withdrawnphase_2

Autologous Transplant To End NMO Spectrum Disorder

NCT03829566
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05675319Phase 3

Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy

Terminated
NCT04735185Not Applicable

Stem Cells vs. Steroids for Discogenic Back Pain

Withdrawn
NCT03342638Phase 3

Maximizing Outcome of Multiple Sclerosis Transplantation

Terminated
NCT03593902Phase 2

Cardiac Safe Transplants for Systemic Sclerosis

Terminated
NCT03829566Phase 2

Autologous Transplant To End NMO Spectrum Disorder

Withdrawn
NCT02038972Phase 1

Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss

Completed
NCT01786707Phase 1

Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus

Completed
NCT00669227Phase 2

Intracoronary Stem Cell Therapy in Patients With Acute Myocardial Infarction (SCAMI)

Completed
NCT00346177Phase 2

Stem Cell Study for Patients With Heart Failure

Withdrawn

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9